On August 15, 2024, the U.S. Food and Drug Administration (FDA) issued draft guidance with new, voluntary sodium reduction targets for foods, with the goal of reducing sodium intake to 2,750 ...
PDS Biotech is a clinical-stage company focused on developing immunotherapy-based approaches for cancer, with a focus on virus-driven tumors. Their main pipeline project is PDS0101, an immunotherapy ...
AC Immune (NASDAQ:ACIU) issued an update on its Phase 2 drug candidates for the treatment of Alzheimer’s and Parkinson diseases and said it has extended its cash runway into 2026 through a $50M equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback